Navigation Links
PrimeChart™

ProductsPrimeChart™
Company Greenway Medical Technologies
Item PrimeChart™
Features 
  • Clinical Alerts, Reminders and Tracking functionality.
  • Customizable encounter data entry templates.
  • Critical patient data is stored discretely.
  • Coding framework is provided whereby users can ensure that CMS (formerly HCFA) and other third-party documentation guidelines are met.
  • Automated prescription writing.
  • Order placement functionality.
  • User-definable links to internal and external resources.
Description PrimeChart™ is the Point-of Care Electronic Medical Record portion of PrimeSuite™. It provides for an automated encounter documentation process and electronic patient record solution within an easy to use interface that is both mobile and secure. Using a variety of user interface technologies, such as pentop technology with a stylus device, physicians can electronically access and update all of their patient records within the practice while seeing patients, as well as having remote access to patient records to assist physicians while on-call or at the hospital.
Info Greenway Medical Technologies
Customer Service: (770) 836-3100
Web site: http://www.greenwaymedical.com

Related medicine products :

1. NextGen EPM (Enterprise Practice Management system)
2. MaximEyes Practice Management and Electronic Medical Records Software Solutions
3. PRAXIS® Electronic Medical Records v. 2.19
4. MaximEyes Optometric & Ophthalmology Software for Practice Management and Electronic Medical Records
5. ExamWRITER Electronic Medical Records
6. PrimeSuite Integrated Practice Management, Electronic Medical Record (EMR) and Managed Care solutions
7. Cardiology Software for Electronic Medical Records
8. HealthMatics EMR Electronic Medical Record
9. Littmann Electronic Stethoscope Model 2000
10. 3M Littmann Electronic Stethoscope Model 4100WS with Ambient Noise Reduction
11. Eppendorf EDOS Electronic Dispensing System
Other Medicine News:Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 2Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 3Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 4Health News:LCA-Vision Announces Termination of Consent Solicitation and Withdrawal of Dissident Slate of Director Nominees 2Health News:Al Copeland Foundation Signs on as Title Sponsor of 2009 Chris Paul Basketball Camp 2Health News:Al Copeland Foundation Signs on as Title Sponsor of 2009 Chris Paul Basketball Camp 3Health News:Thomson Reuters Announces 100 Top Hospitals Award Winners 2Health News:Thomson Reuters Announces 100 Top Hospitals Award Winners 3Health News:Thomson Reuters Announces 100 Top Hospitals Award Winners 4Health News:Thomson Reuters Announces 100 Top Hospitals Award Winners 5Health News:A Star-Filled Evening with The AFA's Illuminations Los Angeles 2Health News:A Star-Filled Evening with The AFA's Illuminations Los Angeles 3Health News:Dr. Rudy Kachmann, Neurosurgeon, Author, Lecturer & Founder of Kachmann Mind Body Institute Selects TransMedia Group as Agency of Record 2
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3HealthFitness Announces Third Quarter 2009 Financial Results 60712 1HealthFitness Announces Third Quarter 2009 Financial Results 60712 2HealthFitness Announces Third Quarter 2009 Financial Results 60712 3HealthFitness Announces Third Quarter 2009 Financial Results 60712 4HealthFitness Announces Third Quarter 2009 Financial Results 60712 5HealthFitness Announces Third Quarter 2009 Financial Results 60712 6HealthFitness Announces Third Quarter 2009 Financial Results 60712 7HealthFitness Announces Third Quarter 2009 Financial Results 60712 8HealthFitness Announces Third Quarter 2009 Financial Results 60712 9HealthFitness Announces Third Quarter 2009 Financial Results 60712 10HealthFitness Announces Third Quarter 2009 Financial Results 60712 11Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 1Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 2Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 3Zyngenia Inc Raises 2410 Million in Series A Funding 14724 1Zyngenia Inc Raises 2410 Million in Series A Funding 14724 2Zyngenia Inc Raises 2410 Million in Series A Funding 14724 3Zyngenia Inc Raises 2410 Million in Series A Funding 14724 4